In 2016, Coast Guard historian Dr
Studies document effects on approximately 31.2% of human genes, representing over 4,000 genes with expression changes of 50% or greater
Recommended Protocol for Post-Weight-Loss Skin Tightening Dosage: 2 mg daily subcutaneous injection Cycle length: 10 to 12 weeks Rest period: 4 to 6 weeks between cycles Injection sites: Rotate between abdomen, upper arms, and thighs Optional addition: Topical GHK-Cu serum (0.5 to 1%) applied to problem areas Cycles per year: 2 to 3 Subcutaneous injection is the preferred route for skin applications because it provides near 100% bioavailability and allows for easy self-administration using 29 to 31 gauge insulin syringes at a 45 to 90 degree angle
Take weekly photos from consistent angles and lighting to track progress objectively
GHK-Cu levels decline with age, and exogenous administration has been shown to stimulate collagen synthesis, accelerate wound healing, and modulate expression of genes involved in tissue remodeling
Regulatory Status None of GLOW Blend's three components GHK-Cu, BPC-157, or TB-500 is approved by the FDA as a drug for any indication